Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(21):1572; doi:10.1093/jnci/96.21.1572
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Travis, K.
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Travis, K.
Right arrow Articles by Zielinski, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

In Brief

Kate Travis, Sarah L. Zielinski

The first 10% of the full text of this article appears below.

Study Finds Most Antioxidant Supplements Provide No Protection Against Gastrointestinal Cancers

A review of clinical trials that tested the effects of antioxidant supplements on the risk of gastrointestinal cancers found that the antioxidants, alone and in combination, were not effective in reducing cancer risk.

In the October 2 issue of The Lancet, Goran Bjelakovic, M.D., of the University of Nis in Serbia and Montenegro, and colleagues reviewed 14 randomized trials that had compared antioxidant supplements with . . . [Full Text of this Article]

Safety Warning Issued on Drugs for Metastatic Bone Disease

Two Trials Suggest Docetaxel Improves Survival in Metastatic Prostate Cancer

Oncogene Inactivation Prompts Tumor Regression in Mice


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
D. Errante, N. Mannucci, D. Bernardi, A. Bianco, and L. Salvagno
Comment on 'Jaw avascular bone necrosis associated with long-term use of biphosphonates'
Ann. Onc., February 1, 2006; 17(2): 350 - 352.
[Full Text] [PDF]